Sandra Calvin insider trades
Open-market stock purchases and sales by Sandra Calvin, SVP, CHIEF ACCOUNTING OFFICER at Travere Therapeutics, Inc, from SEC Form 4 filings since Jan 24, 2022.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $266K |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $50.3K |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Sold | $19.1K |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Sep 15, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Sold | $903K |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Apr 14, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Feb 3, 2026 | TVTX Travere Therapeutics, Inc | Sold | $139K |
| Jan 31, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Jan 31, 2026 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Dec 24, 2025 | TVTX Travere Therapeutics, Inc | Sold | $296K |
| Dec 15, 2025 | TVTX Travere Therapeutics, Inc | Sold | $105K |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc | Sold | $2.4M |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
| Nov 4, 2025 | TVTX Travere Therapeutics, Inc | Bought (not open market) | — |
Companies traded
- TVTX Travere Therapeutics, Inc: 28 sales, last Sep 15, 2026